Allergy Arachis hypogaea (pinda) allergenen (capsule) Arachis hypogaea (pinda) allergenen (pleister) Olopatadine / mometasone Omalizumab IND Bowel diseases Adalimumab IND Alicaforsen Pouchitis Ulcerative colitis Filgotinib Remestemcel-L IND Tenapanor Upadacitinib IND Cardiovascular diseases Avacopan Sutimlimab Other chronic immune diseases Anakinra IND Belatacept IND Belimumab IND Berotralstat Elobixibat Emapalumab Forigerimod Icatibant G Imlifidase Lanadelumab Naldemedine RP-L201 Teprasiran Teprotumumab Triamcinolone Voclosporin Rheumatism Anifrolumab Filgotinib Guselkumab IND Ixekizumab IND Olokizumab Secukinumab IND Tocilizumab BS Tofacitinib Treatment of active polyarticular course juvenile idiopathic arthritis patients 2 years of age and older. IND Ankylosing Spondylitis IND Upadacitinib Extension of indication to include the treatment of active ankylosing spondylitis in adult patient for Rinvoq IND RINVOQ is indicated for the treatment of active psoriatic arthritis in adult patients who haveresponded inadequately to, or who are intolerant to one or more DMARD. RINVOQ may be used as monotherapy or in combination with nonbiologic DMARDs. IND Ustekinumab IND Skin diseases Abrocitinib Baricitinib IND Beremagene geperpavec Berkenschorsextract IND Bimekizumab Clascoterone Crisaborole Difelikefalin Dupilumab IND Glycopyrronium tosylate Ixekizumab IND Lebrikizumab Nemolizumab Secukinumab IND Tapinarof Adult Plaque Psoriasis Atopische dermatitis Tirbanibulin Tralokinumab Trifarotene Upadacitinib IND